IONIS PHARMACEUTICALS INC — Director's Dealing 2019

Nov 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-11-20

Reporting Person: KLEIN JOSEPH III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-20	Common Stock	S	2000	$60.00	Disposed	13495	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Indirect

Footnotes

F1: The sale of shares owned was made pursuant to a 10b5-1 Trading Plan adopted by the reporting person on 10/11/2019.